ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Novartis Pharma Schweiz AG - Optaflu, Injektionssuspension
5827101
OptafluInjektionssuspension
J07BB02Influenza, Inactivated, Split Virus Or Surface Antigen
28.05.2009  
Composition
haemagglutininum influenzae A (H1N1) (A/New Caledonia/20/99 - like Reass., IVR-116) 15 µg, haemagglutininum influenzae A (H3N2) (A/California/7/2004 - like NYMC X-157) 15 µg, haemagglutininum influenzae B (Shanghai/361/2002 -like B/Jiangsu/10/2003) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.
Packungsbestandteile
Injection suspension
  
Active Agent
Vaccinum Influenzae Inactivatum ex Corticis Antigeniis Praeparatum (Cellulae Mdck) 2015/2016
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
0070.5 ml10.0519.70B Yes
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home